ASCEND BY NTHRYS
Research Abroad Products

Molecular Diagnostics Project Topics

Browse all focused areas across all project categories under this field.

Showing 13–24 of 200 project topics
Liquid Biopsy NGS Service for Early Cancer Detection Screening
A commercial NGS service targeting cfDNA analysis from blood samples for non-invasive early-stage cancer detection across multiple tumor types. This high-margin service taps the growing preventive oncology market, with potential for direct-to-consumer partnerships and insurance reimbursement at $2,000-$5,000 per test.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
Microorganism Identification NGS Platform for Infection Management
An industry-grade NGS diagnostic tool that identifies bacterial, fungal, and viral pathogens with antimicrobial resistance profiling in 48-72 hours. This reduces empiric antibiotic use, improves patient outcomes, and generates revenue through hospital laboratory adoption and outbreak management contracts.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
Prenatal and Noninvasive Prenatal Testing NGS Commercial Kit
A comprehensive NIPT NGS product screening for chromosomal abnormalities, microdeletions, and monogenic disorders from maternal cell-free DNA. High consumer demand, insurance coverage, and recurring test volumes position this as a high-volume revenue driver with 20-30% gross margins.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
Pharmacogenomics NGS Testing Platform for Precision Medicine
A targeted NGS service profiling clinically actionable pharmacogenes to optimize medication selection and dosing for individual patients. This enables partnerships with pharmaceutical companies, healthcare systems, and pharmacy benefit managers, creating multiple revenue streams through testing fees and data licensing.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
Exome Sequencing Service with Automated Clinical Reporting Pipeline
A fully automated NGS-based whole exome sequencing service incorporating AI-driven variant prioritization and structured clinical reports ready for physician delivery. The streamlined workflow reduces turnaround time to 10-14 days and enables volume scaling with minimal additional personnel, improving per-test profitability.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
Hereditary Cancer Risk Assessment NGS Panel as Clinical Service
A commercial NGS testing service analyzing germline mutations in cancer predisposition genes for risk stratification and preventive care planning. Recurring patient testing, genetic counseling add-ons, and family-member screening create multiple touchpoints for revenue generation and patient lifetime value.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
Tissue-Based Solid Tumor Profiling NGS with Treatment Matching
An integrated NGS diagnostic platform that profiles tumor genomics and algorithmically matches patients to targeted therapies, immunotherapies, and clinical trials. Partnerships with oncology networks and pharmaceutical companies enable service fees, data licensing, and patient enrollment incentives.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
White-Label NGS Diagnostic Platform for Laboratory Operators
A turnkey NGS software and workflow solution that clinical laboratories license to operate their own branded diagnostic services without upfront sequencing infrastructure investment. This B2B2C model generates recurring licensing fees, testing royalties, and consumable sales while enabling rapid market expansion.
NGS-Based Clinical Diagnostic Platform Development Click to view more details →
AI-Powered Rare Disease Variant Interpretation SaaS
A cloud-based platform that leverages machine learning to automatically classify and interpret genomic variants associated with rare diseases in real-time. This reduces manual curation costs by 70% and enables labs to deliver faster, more accurate diagnostic reports, creating recurring subscription revenue.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Multi-Gene Panel Sequencing Kit with Cloud Analytics
A commercial sequencing reagent kit targeting 500+ rare disease-associated genes paired with proprietary cloud software for data analysis and reporting. The kit generates high-margin consumable sales while the analytics platform provides ongoing SaaS licensing revenue from clinical laboratories.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Real-Time Liquid Biopsy Platform for Rare Disease Monitoring
A point-of-care diagnostic tool that detects circulating biomarkers from blood samples to monitor disease progression in rare genetic disorders. This enables continuous patient monitoring revenue models through subscription-based testing programs and direct-to-consumer partnerships.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →
Rare Disease Genetic Counseling Automation Software
An enterprise SaaS platform that automates pre- and post-test genetic counseling workflows using natural language processing and clinical decision trees. Healthcare systems reduce counseling bottlenecks while maintaining compliance, unlocking significant operational cost savings and reimbursement optimization.
Molecular Diagnostics Rare Disease Platform Dev Click to view more details →